Gross Margin
22.76%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 25.42%.Updated Aug 20, 2026Profit Margin
-3.34%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
-3.86%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
-0.23%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
-4.00%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
1.05BCNY155.83M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
2.73CNYUpdated Aug 20, 2026Quarterly Revenue Growth
-14.90%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
266.71MCNY39.61M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
96.51MCNY14.33M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
-35.06MCNY-5.21M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
-38.81%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
118.14MCNY17.55M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-57.43MCNY-8.53M · vs all stocks (USD) Updated Aug 20, 20265-Year Average Dividend Yield
1.10%Updated Aug 20, 2026Minority Interest (Equity)
-736.29KCNYFY2025 · Dec 31, 2025Revenue
1.09BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
807.81MCNYFY2025 · Dec 31, 2025Gross Profit
277.90MCNYFY2025 · Dec 31, 2025Operating Income
21.61MCNY3.21M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-29.14MCNYFY2025 · Dec 31, 2025Income Tax Expense
-674.32KCNYFY2025 · Dec 31, 2025Net Income
-28.47MCNYFY2025 · Dec 31, 2025EBIT
-5.38MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
96.51MCNYFY2025 · Dec 31, 2025Research & Development
49.36MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
77.79MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.12MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
253.74KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
23.76MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0720CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0720CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
385.13MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
385.13MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-28.47MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
736.29KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
91.42MCNYFY2025 · Dec 31, 2025Free Cash Flow
-167.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
120.69MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-28.47MCNYFY2025 · Dec 31, 2025Other Non-cash Items
29.04MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
64.62MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
26.22MCNYFY2025 · Dec 31, 2025Capital Expenditures
-258.44MCNYFY2025 · Dec 31, 2025Sale of Investments
465.55KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-257.97MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
533.92MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-420.35MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-62.86MCNYFY2025 · Dec 31, 2025Other Financing Charges
-8.12MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
42.60MCNYFY2025 · Dec 31, 2025